Literature DB >> 17987883

HIV-associated oral Kaposi sarcoma and HHV-8: a review.

Liviu Feller1, Johan Lemmer, Neil H Wood, Yusuf Jadwat, Erich J Raubenheimer.   

Abstract

Kaposi sarcoma is the most common malignant tumour associated with HIV infection. In the majority of cases oral tissues are involved and in 22% the initial presentation is in the oral cavity. The oral lesions are either single or multifocal, and the palate, gingiva and tongue are the sites most frequently involved. The pathogenesis of Kaposi sarcoma in HIV-seropositive subjects is complex. It involves interaction between human herpesvirus-8 (HHV-8) and HIV, altered cellular signal transduction pathways, and increased production of cytokines and growth factors. The multifactorial nature and clinical stages in the growth of oral Kaposi sarcoma are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17987883

Source DB:  PubMed          Journal:  J Int Acad Periodontol        ISSN: 1466-2094


  10 in total

1.  MicroRNA expression profiles in Kaposi's sarcoma.

Authors:  Ana Maria Catrina Ene; Ioana Borze; Mohamed Guled; Mariana Costache; Gayle Leen; Maria Sajin; Elena Ionica; Aura Chitu; Sakari Knuutila
Journal:  Pathol Oncol Res       Date:  2013-09-13       Impact factor: 3.201

2.  Angiopoietin-like 4: a novel molecular hallmark in oral Kaposi's sarcoma.

Authors:  Jiadi Hu; Bruno C Jham; Tao Ma; Eitan R Friedman; Leticia Ferreira; John M Wright; Brent Accurso; Carl M Allen; John R Basile; Silvia Montaner
Journal:  Oral Oncol       Date:  2011-03-21       Impact factor: 5.337

3.  Short-chain fatty acids from periodontal pathogens suppress histone deacetylases, EZH2, and SUV39H1 to promote Kaposi's sarcoma-associated herpesvirus replication.

Authors:  Xiaolan Yu; Abdel-Malek Shahir; Jingfeng Sha; Zhimin Feng; Betty Eapen; Stanley Nithianantham; Biswajit Das; Jonathan Karn; Aaron Weinberg; Nabil F Bissada; Fengchun Ye
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

4.  Kaposi sarcoma-associated herpesvirus (KSHV) induces a functional tumor-associated phenotype for oral fibroblasts.

Authors:  Lu Dai; Zhiqiang Qin; Michael Defee; Bryan P Toole; Keith L Kirkwood; Chris Parsons
Journal:  Cancer Lett       Date:  2011-12-17       Impact factor: 8.679

5.  Auricular involvement of a multifocal non-AIDS Kaposi's sarcoma: a case report.

Authors:  M Busi; E Altieri; A Ciorba; C Aimoni
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-04       Impact factor: 2.124

6.  The malignant potential of HIV-associated Kaposi sarcoma.

Authors:  Neil H Wood; Liviu Feller
Journal:  Cancer Cell Int       Date:  2008-10-31       Impact factor: 5.722

7.  Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa.

Authors:  Razia A G Khammissa; Liron Pantanowitz; Liviu Feller
Journal:  AIDS Res Treat       Date:  2012-09-12

8.  The prognostic significance of facial lymphoedema in HIV-seropositive subjects with Kaposi sarcoma.

Authors:  L Feller; Jn Masipa; Nh Wood; Ej Raubenheimer; J Lemmer
Journal:  AIDS Res Ther       Date:  2008-01-29       Impact factor: 2.250

9.  Oral Kaposi Sarcoma in HIV-seronegative Saudi patient: Literature review and case report.

Authors:  Asmaa Faden; Manal AlSheddi; Mohammed AlKindi; Lama Alabdulaaly
Journal:  Saudi Dent J       Date:  2017-05-03

10.  Transcriptomic analysis of KSHV-infected primary oral fibroblasts: The role of interferon-induced genes in the latency of oncogenic virus.

Authors:  Lu Dai; Lihua Bai; Zhen Lin; Jing Qiao; Liang Yang; Erik K Flemington; Jovanny Zabaleta; Zhiqiang Qin
Journal:  Oncotarget       Date:  2016-07-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.